Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Changes in Stockholders' Equity

v3.23.1
Condensed Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2021 $ 2 $ 111,588 $ (89,368) $ 22,222
Balance (in shares) at Dec. 31, 2021 18,845,828      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock in connection with the at-the-market program $ 0 1,208 0 1,208
Issuance of common stock in connection with the at-the-market program (in shares) 336,544      
Issuance costs $ 0 (35) 0 (35)
Stock-based compensation $ 0 445 0 445
Stock-based compensation (in shares) 6,970      
Exercise of stock options $ 0 27 0 27
Exercise of stock options (in shares) 24,309      
Net and comprehensive loss $ 0 0 (6,595) (6,595)
Balance at Mar. 31, 2022 $ 2 113,233 (95,963) 17,272
Balance (in shares) at Mar. 31, 2022 19,213,651      
Balance at Dec. 31, 2022 $ 2 117,717 (71,480) 46,239
Balance (in shares) at Dec. 31, 2022 20,861,315      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance costs $ 0 (2) 0 (2)
Stock-based compensation $ 0 804 0 804
Stock-based compensation (in shares) 68,646      
Exercise of warrants $ 0 0 0 0
Exercise of warrants (in shares) 17,869      
Net and comprehensive loss $ 0 0 (5,791) (5,791)
Balance at Mar. 31, 2023 $ 2 $ 118,519 $ (77,271) $ 41,250
Balance (in shares) at Mar. 31, 2023 20,947,830